These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 19941995)

  • 1. The cAMP assay: a functional in vitro alternative to the in vivo Histamine Sensitization test.
    Hoonakker ME; Ruiterkamp N; Hendriksen CF
    Vaccine; 2010 Feb; 28(5):1347-52. PubMed ID: 19941995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reporter cell lines for detection of pertussis toxin in acellular pertussis vaccines as a functional animal-free alternative to the in vivo histamine sensitization test.
    Hoonakker ME; Verhagen LM; van der Maas L; Sloots A; Hendriksen CFM
    Vaccine; 2017 Feb; 35(8):1152-1160. PubMed ID: 28129894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specificity and detection limit of a dermal temperature histamine sensitization test for absence of residual pertussis toxin in vaccines.
    Jensen SE; Illigen KE; Badsberg JH; Hasløv KR
    Biologicals; 2012 Jan; 40(1):36-40. PubMed ID: 22000164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Collaborative study for the standardisation of the histamine sensitizing test in mice and the CHO cell-based assay for the residual toxicity testing of acellular pertussis vaccines.
    Xing D; Maes A; Behr-Gross ME; Costanzo A; Daas A; Buchheit KH
    Pharmeur Bio Sci Notes; 2010 Apr; 2010(1):51-63. PubMed ID: 20223190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highly sensitive histamine-sensitization test for residual activity of pertussis toxin in acellular pertussis vaccine.
    Ochiai M; Yamamoto A; Kataoka M; Toyoizumi H; Arakawa Y; Horiuchi Y
    Biologicals; 2007 Oct; 35(4):259-64. PubMed ID: 17363269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An alternative temperature-based histamine-sensitisation test for absence of residual pertussis toxin in acellular pertussis vaccines.
    Jensen SE; Engelhart Illigen KE; Hasløv KR
    Pharmeur Bio Sci Notes; 2010 Apr; 2010(1):73-4. PubMed ID: 20223192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ADP-ribosylation activity in pertussis vaccines and its relationship to the in vivo histamine-sensitisation test.
    Gomez SR; Yuen CT; Asokanathan C; Douglas-Bardsley A; Corbel MJ; Coote JG; Parton R; Xing DK
    Vaccine; 2007 Apr; 25(17):3311-8. PubMed ID: 17287049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modified binding assay for improved sensitivity and specificity in the detection of residual pertussis toxin in vaccine preparations.
    Isbrucker RA; Bliu A; Prior F
    Vaccine; 2010 Mar; 28(15):2687-92. PubMed ID: 20123053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved protocols for histamine sensitization testing of acellular pertussis vaccines.
    Oh H; Joung J; Kim BG; Nam KT; Hong SH; Song HC; Lee HL; Ahn BY
    Vaccine; 2012 Nov; 30(50):7246-52. PubMed ID: 23084771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of residual pertussis toxin in vaccines using a modified ribosylation assay.
    Yuen CT; Canthaboo C; Menzies JA; Cyr T; Whitehouse LW; Jones C; Corbel MJ; Xing D
    Vaccine; 2002 Nov; 21(1-2):44-52. PubMed ID: 12443661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pertussis toxin-induced histamine sensitisation: an aspecific phenomenon independent from the nitric oxide system?
    van Meijeren CE; Vleeming W; van de Kuil T; Gerards AL; Hendriksen CF; de Wildt DJ
    Eur J Pharmacol; 2004 Jun; 493(1-3):139-50. PubMed ID: 15189775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of a safe, potent and immunogenic partially purified acellular pertussis vaccine using simple indigenous techniques.
    Gupta RK; Saxena SN; Sharma SB; Ahuja S
    Dev Biol Stand; 1991; 73():205-22. PubMed ID: 1778314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assays for Determining Pertussis Toxin Activity in Acellular Pertussis Vaccines.
    Markey K; Asokanathan C; Feavers I
    Toxins (Basel); 2019 Jul; 11(7):. PubMed ID: 31319496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pertussis toxin and the adenylate cyclase toxin from Bordetella pertussis activate human monocyte-derived dendritic cells and dominantly inhibit cytokine production through a cAMP-dependent pathway.
    Bagley KC; Abdelwahab SF; Tuskan RG; Fouts TR; Lewis GK
    J Leukoc Biol; 2002 Nov; 72(5):962-9. PubMed ID: 12429718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In search of acceptable alternatives to the murine histamine sensitisation test (HIST): what is possible and practical?
    Wagner L; Isbrucker R; Locht C; Arciniega J; Costanzo A; McFarland R; Oh H; Hoonakker M; Descamps J; Andersen SR; Gupta RK; Markey K; Chapsal JM; Lidster K; Casey W; Allen D
    Pharmeur Bio Sci Notes; 2016; 2016():151-170. PubMed ID: 28279256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Towards replacement of the acellular pertussis vaccine safety test: Comparison of in vitro cytotoxic activity and in vivo activity in mice.
    Wagner LD; Corvette LJ; Ngundi MM; Burns DL
    Vaccine; 2017 Dec; 35(51):7160-7165. PubMed ID: 29122386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assay of pertussis vaccine reactivity factors by measurement of the paw swelling response, endotoxin and histamine-sensitizing factor.
    Vuolo AM; Lustigman B
    Biologicals; 1993 Mar; 21(1):45-52. PubMed ID: 8217117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pertussis serological potency test as an alternatively to the intracerebral mouse protection test.
    van der Ark A; van Straaten-van de Kappelle I; Hendriksen C; van de Donk H
    Dev Biol Stand; 1996; 86():271-81. PubMed ID: 8785956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Collaborative study on test systems to assess toxicity of whole cell pertussis vaccine.
    van Straaten-van de Kappelle I; van der Gun JW; Marsman FR; Hendriksen CF; van de Donk HJ
    Biologicals; 1997 Mar; 25(1):41-57. PubMed ID: 9167008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The quantitative analysis of the mechanism involved in pertussis toxin-mediated cell clustering and its implications in the in vitro quality control of diphtheria tetanus and whole cell pertussis vaccines.
    Zamith HPDS; Godinho RO; da Costa Junior VL; Corrado AP
    Toxicol In Vitro; 2021 Feb; 70():105029. PubMed ID: 33059000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.